VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded down 5.6% during mid-day trading on Monday . The stock traded as low as C$0.17 and last traded at C$0.17. 76,618 shares were traded during mid-day trading, a decline of 14% from the average session volume of 88,672 shares. The stock had previously closed at C$0.18.
VentriPoint Diagnostics Stock Down 5.6 %
The firm has a 50-day simple moving average of C$0.20 and a 200 day simple moving average of C$0.22. The company has a market capitalization of C$26.72 million, a PE ratio of -5.67 and a beta of 0.43. The company has a debt-to-equity ratio of 217.41, a current ratio of 0.42 and a quick ratio of 6.67.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- What is MarketRank™? How to Use it
- Why Block’s Key Components Make It a Solid Investment Choice
- How to Use the MarketBeat Excel Dividend Calculator
- Is Applied Digital’s Stock Set to Surge With NVIDIA’s Backing?
- How to Most Effectively Use the MarketBeat Earnings Screener
- 4 Reasons to Consider Adding General Mills to Your Portfolio
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
